{"nct_id":"NCT05024058","title":"Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- Antihistamines","status":"TERMINATED","status_verified_date":"2024-06","start_date":"2021-11-16","start_date_type":"ACTUAL","primary_completion_date":"2022-08-09","primary_completion_date_type":"ACTUAL","completion_date":"2022-08-09","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}